Therefore, nuclear and cytoplasmic fractionation followed by qRT-PCR revealed the presence of CASC19 in the nuclear fraction of the pancreatic cancer cell MIAPaCa-2 (Fig. 4A). The gene discussed is CASC19; the disease is pancreatic neoplasm.